Tessellate BIO

Tessellate BIO Emerges from Stealth with €8 Million in Seed Funding, Pioneering Novel Synthetic Lethality Approaches in Oncology

Tessellate BIO, a preclinical stage biotechnology company specializing in innovative Synthetic Lethality approaches, made its official debut from stealth today…